CO2018007271A2 - New derivatives of phosphinanes and azaphosphinans, their preparation process and the pharmaceutical compositions containing them - Google Patents
New derivatives of phosphinanes and azaphosphinans, their preparation process and the pharmaceutical compositions containing themInfo
- Publication number
- CO2018007271A2 CO2018007271A2 CONC2018/0007271A CO2018007271A CO2018007271A2 CO 2018007271 A2 CO2018007271 A2 CO 2018007271A2 CO 2018007271 A CO2018007271 A CO 2018007271A CO 2018007271 A2 CO2018007271 A2 CO 2018007271A2
- Authority
- CO
- Colombia
- Prior art keywords
- azaphosphinans
- phosphinanes
- pharmaceutical compositions
- preparation process
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6568—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
- C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
- C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
- C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Compuestos de fórmula (I) (ver imágen adjunto) en la que: Ak1 representa una cadena alquilo, X representa -(CH2)m-, -CH(R)-, -N(R)-, -CH2-N(R)-, –N(R)-CH2- o -CH2-N(R)-CH2-, m y R son tales como se han definido en la descripción, R1 y R2 representan cada uno H cuando X representa -(CH2)m-, -CH(R)-, -N(R)-, -CH2-N(R)- o –N(R)-CH2-, o bien forman juntos una unión cuando X representa -CH2-N(R)-CH2-, R3 representa NH2, Cy-NH2, Cy-Ak3-NH2 o piperidin-4-ilo, Cy y Ak3 son tales como se han definido en la descripción, R4 y R5, idénticos o diferentes, representan cada uno H o F, sus isómeros ópticos, así como sus sales de adición a un ácido farmacéuticamente aceptable. Medicamentos.Compounds of formula (I) (see attached image) in which: Ak1 represents an alkyl chain, X represents - (CH2) m-, -CH (R) -, -N (R) -, -CH2-N (R ) -, -N (R) -CH2- or -CH2-N (R) -CH2-, m and R are as defined in the description, R1 and R2 each represent H when X represents - (CH2) m -, -CH (R) -, -N (R) -, -CH2-N (R) - or –N (R) -CH2-, or together form a joint when X represents -CH2-N (R) -CH2-, R3 represents NH2, Cy-NH2, Cy-Ak3-NH2 or piperidin-4-yl, Cy and Ak3 are as defined in the description, R4 and R5, identical or different, each represent H or F, its optical isomers, as well as its addition salts to a pharmaceutically acceptable acid. Medicines.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1670004A FR3046793B1 (en) | 2016-01-14 | 2016-01-14 | NOVEL PHOSPHINAN DERIVATIVES AND AZAPHOSPHINANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
PCT/FR2017/050075 WO2017121969A1 (en) | 2016-01-14 | 2017-01-13 | Novel phosphinane and azaphosphinane derivatives, method for preparing same and pharmaceutical compositions containing same |
Publications (1)
Publication Number | Publication Date |
---|---|
CO2018007271A2 true CO2018007271A2 (en) | 2018-07-19 |
Family
ID=55752640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CONC2018/0007271A CO2018007271A2 (en) | 2016-01-14 | 2018-07-12 | New derivatives of phosphinanes and azaphosphinans, their preparation process and the pharmaceutical compositions containing them |
Country Status (47)
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3046793B1 (en) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | NOVEL PHOSPHINAN DERIVATIVES AND AZAPHOSPHINANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA03001425A (en) * | 2000-08-17 | 2003-06-06 | Pfizer | PHARMACEUTICAL COMPOUNDS. |
SE0103272D0 (en) * | 2001-09-28 | 2001-09-28 | Astrazeneca Ab | Chemical compounds |
WO2003076416A1 (en) * | 2002-03-08 | 2003-09-18 | Warner-Lambert Company Llc | Oxo azabicyclic compounds |
US7420000B2 (en) * | 2003-09-10 | 2008-09-02 | University Of Southern California | Amino phosphonate and amino bis-phosphonate derivatives |
US20050143349A1 (en) * | 2003-12-17 | 2005-06-30 | Quatrx Pharmaceuticals Co. | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels |
CA2604912A1 (en) * | 2005-04-18 | 2006-10-26 | Bayer Schering Pharma Aktiengesellschaft | Use of tafi inhibitors for enhanced myocardial reperfusion and facilitated pci |
JP5478488B2 (en) * | 2007-06-20 | 2014-04-23 | メルク・シャープ・アンド・ドーム・コーポレーション | JANUS kinase inhibitors |
FR2920773B1 (en) * | 2007-09-11 | 2009-10-23 | Servier Lab | 1,2,4,5-TETRAHYDRO-3H-BENZAZEPINES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2947266B1 (en) * | 2009-06-26 | 2011-06-17 | Servier Lab | NOVEL 2-MERCAPTOCYCLOPENTANECARBOXYLIC ACID DERIVATIVES, PROCESS FOR PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME |
PT2507249E (en) * | 2009-09-09 | 2016-02-15 | Gilead Sciences Inc | Inhibitors of flaviviridae viruses |
JP6186434B2 (en) * | 2012-07-18 | 2017-08-23 | サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. | Nitrogen heterocyclic derivatives and their applications in medicine |
FR3046793B1 (en) * | 2016-01-14 | 2018-01-05 | Les Laboratoires Servier | NOVEL PHOSPHINAN DERIVATIVES AND AZAPHOSPHINANES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
-
2016
- 2016-01-14 FR FR1670004A patent/FR3046793B1/en not_active Expired - Fee Related
- 2016-12-27 JO JOP/2016/0275A patent/JO3660B1/en active
-
2017
- 2017-01-11 UY UY0001037072A patent/UY37072A/en unknown
- 2017-01-12 TW TW106100930A patent/TWI625334B/en not_active IP Right Cessation
- 2017-01-12 AR ARP170100074A patent/AR107433A1/en unknown
- 2017-01-13 TR TR2018/20430T patent/TR201820430T4/en unknown
- 2017-01-13 MD MDE20180097T patent/MD3271368T2/en not_active IP Right Cessation
- 2017-01-13 EA EA201891599A patent/EA035072B1/en not_active IP Right Cessation
- 2017-01-13 UA UAA201808634A patent/UA121275C2/en unknown
- 2017-01-13 MX MX2018008639A patent/MX367319B/en active IP Right Grant
- 2017-01-13 PT PT17706525T patent/PT3271368T/en unknown
- 2017-01-13 PL PL17706525T patent/PL3271368T3/en unknown
- 2017-01-13 PE PE2018001210A patent/PE20181503A1/en unknown
- 2017-01-13 WO PCT/FR2017/050075 patent/WO2017121969A1/en active Application Filing
- 2017-01-13 JP JP2018536455A patent/JP2019504070A/en active Pending
- 2017-01-13 RU RU2018129027A patent/RU2729641C2/en not_active IP Right Cessation
- 2017-01-13 LT LTEP17706525.7T patent/LT3271368T/en unknown
- 2017-01-13 CU CUP2018000072A patent/CU20180072A7/en unknown
- 2017-01-13 DK DK17706525.7T patent/DK3271368T3/en active
- 2017-01-13 EP EP17706525.7A patent/EP3271368B1/en active Active
- 2017-01-13 CA CA3011184A patent/CA3011184C/en not_active Expired - Fee Related
- 2017-01-13 RS RS20190105A patent/RS58338B1/en unknown
- 2017-01-13 AU AU2017207003A patent/AU2017207003B2/en not_active Expired - Fee Related
- 2017-01-13 HU HUE17706525A patent/HUE042924T2/en unknown
- 2017-01-13 KR KR1020187023228A patent/KR20180101522A/en active IP Right Grant
- 2017-01-13 SG SG11201805757WA patent/SG11201805757WA/en unknown
- 2017-01-13 ME MEP-2019-23A patent/ME03305B/en unknown
- 2017-01-13 SI SI201730013T patent/SI3271368T1/en unknown
- 2017-01-13 ES ES17706525T patent/ES2709376T3/en active Active
- 2017-01-13 MA MA41798A patent/MA41798B1/en unknown
- 2017-01-13 GE GEAP201714853A patent/GEP20207092B/en unknown
- 2017-01-13 BR BR112018014020-1A patent/BR112018014020A2/en not_active IP Right Cessation
- 2017-01-13 US US15/548,533 patent/US10138260B2/en not_active Expired - Fee Related
- 2017-01-13 TN TNP/2018/000226A patent/TN2018000226A1/en unknown
- 2017-01-13 CN CN201780008078.XA patent/CN108495857A/en active Pending
-
2018
- 2018-03-19 HK HK18103808.6A patent/HK1244283B/en not_active IP Right Cessation
- 2018-06-26 PH PH12018501373A patent/PH12018501373A1/en unknown
- 2018-06-29 ZA ZA2018/04391A patent/ZA201804391B/en unknown
- 2018-07-04 IL IL260425A patent/IL260425B/en active IP Right Grant
- 2018-07-05 SV SV2018005721A patent/SV2018005721A/en unknown
- 2018-07-06 NI NI201800073A patent/NI201800073A/en unknown
- 2018-07-09 CL CL2018001862A patent/CL2018001862A1/en unknown
- 2018-07-09 DO DO2018000165A patent/DOP2018000165A/en unknown
- 2018-07-11 EC ECSENADI201851972A patent/ECSP18051972A/en unknown
- 2018-07-12 CO CONC2018/0007271A patent/CO2018007271A2/en unknown
- 2018-10-04 US US16/151,597 patent/US10654878B2/en active Active
- 2018-12-10 CY CY20181101320T patent/CY1121154T1/en unknown
-
2019
- 2019-01-30 HR HRP20190193TT patent/HRP20190193T1/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112016026205A8 (en) | smn2 gene splicing modulators, their use and their preparation process, and pharmaceutical compositions | |
ECSP109944A (en) | NEW DERIVATIVES OF 6-TRIAZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS | |
NI201800132A (en) | NEW PIPERIDINYL DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
GT201600085A (en) | COMPOSITIONS AND METHODS TO MODULATE X PHARNESOID RECEPTORS | |
EA201401292A2 (en) | NEW THYENOPYRIMIDINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
UY30859A1 (en) | NEW DERIVATIVES OF 2-ANILINO-4-HETEROARILPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND ESPECIALLY AS IKK INHIBITORS | |
EA201890123A1 (en) | NEW AMINO ACID DERIVATIVES, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CU20140095A7 (en) | NEW PHOSPHATE DERIVATIVES, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
UY30857A1 (en) | NEW DERIVATIVES OF N, N'-2,4 DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND ESPECIALLY AS IKK INHIBITORS | |
UY33501A (en) | Acyl sulfonamide derivatives and their pharmaceutically acceptable salts for use in medicine | |
GT201400144A (en) | NEW DERIVATIVES OF PIRROL, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
UY30856A1 (en) | NEW DERIVATIVES OF 2,4 DIANILINOPIRIMIDINAS, ITS PREPARATION, AS MEDICINES, PHARMACEUTICAL COMPOSITIONS AND MAINLY AS IKK INHIBITORS | |
CO2018001700A2 (en) | Derivatives of n- [1h-benzimidazol-2-yl] methyl-pyrazin-2-yl-carboxamide, compositions and methods of preparation thereof | |
AR109168A1 (en) | SALES OF DERIVATIVES OF 2,6-DIMETHYL PIRIMIDONE AND ITS USES | |
ECSP13012838A (en) | NEW BENZODIOXOL-PIPERAZINA COMPOUNDS | |
CL2022001741A1 (en) | Cyclic compounds and methods of using same | |
CO2018007271A2 (en) | New derivatives of phosphinanes and azaphosphinans, their preparation process and the pharmaceutical compositions containing them | |
ECSP12012329A (en) | NEW ASSOCIATION BETWEEN 4- {3- [CIS-HEXAHYDROCICLOPENTA [C] PIRROL-2 (1H) -IL] PROPOXI} BENZAMIDA AND AN ANTAGONIST OF NMDA RECEPTORS AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT | |
AR061740A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PRAPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
AR061741A1 (en) | NEW NAFTALENIC DERIVATIVES, THEIR PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
UY33072A (en) | NEW DERIVATIVES OF AZABICICLO [3.1.0.] HEX-2-ILO, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
CO6400222A2 (en) | DERIVATIVES OF 6- (6-O-CICLOALQUIL OR 6-NH-CICLOALQUIL-TRIAZOLOPIRIDAZINA-SULFANIL) BENZOTIAZOLES AND BENCIMIDAZOLS: PREPARATION, APPLICATION AS MEDICATIONS AND USE AS METHOD INHIBITORS |